[
    [
        {
            "time": "",
            "original_text": "年报里的医药增长密码：集采疫情内外因素跌宕 创新药时代来临18家药企研发增超100%",
            "features": {
                "keywords": [
                    "医药",
                    "集采",
                    "疫情",
                    "创新药",
                    "研发"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "年报里的医药增长密码：集采疫情内外因素跌宕 创新药时代来临18家药企研发增超100%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "恒瑞医药(600276.SH)：注射用卡瑞利珠单抗获得美国FDA孤儿药资格认定",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "卡瑞利珠单抗",
                    "FDA",
                    "孤儿药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药(600276.SH)：注射用卡瑞利珠单抗获得美国FDA孤儿药资格认定",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "2000亿医药主题基金短线榜单 葛兰、赵蓓、吴兴武谁的基金一季度扛住了？",
            "features": {
                "keywords": [
                    "医药基金",
                    "葛兰",
                    "赵蓓",
                    "吴兴武",
                    "一季度"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2000亿医药主题基金短线榜单 葛兰、赵蓓、吴兴武谁的基金一季度扛住了？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "恒瑞医药：注射用卡瑞利珠单抗获得美国FDA孤儿药资格认定",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "卡瑞利珠单抗",
                    "FDA",
                    "孤儿药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药：注射用卡瑞利珠单抗获得美国FDA孤儿药资格认定",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "恒瑞医药今日大宗交易成交270万股，成交价79.55元折价3.4%",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易",
                    "折价"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药今日大宗交易成交270万股，成交价79.55元折价3.4%",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "高瓴、爱尔齐押注的兆科眼科，能否留住光环",
            "features": {
                "keywords": [
                    "高瓴",
                    "爱尔",
                    "兆科眼科"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "高瓴、爱尔齐押注的兆科眼科，能否留住光环",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-04-28",
            "original_text": "A股融资融券日报：两融余额增加19.61亿元（4月28日）",
            "features": {
                "keywords": [
                    "两融余额",
                    "A股",
                    "融资融券"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加19.61亿元（4月28日）",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "创新药的焦虑时刻：3成初创药企股价破发、近百个临床项目围剿热门靶点 连续下跌",
            "features": {
                "keywords": [
                    "创新药",
                    "股价破发",
                    "临床项目",
                    "热门靶点"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "创新药的焦虑时刻：3成初创药企股价破发、近百个临床项目围剿热门靶点 连续下跌",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "财信证券基金行业点评：主动权益型基金21年1季报持仓分析",
            "features": {
                "keywords": [
                    "财信证券",
                    "基金",
                    "主动权益型",
                    "持仓分析"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "财信证券基金行业点评：主动权益型基金21年1季报持仓分析",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]